Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution

Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients

Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?

The Application of Evidence-Based Medicine in Individualized Medicine

Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience

Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy

Posterpräsentation auf der Jahrestagung der Association for Cancer Immunotherapy

Poster presentation at the International Symposium on Pediatric Neuro-Oncology